Telangana DCA Seizes Overpriced Anti-Cancer Medicine In Karimnagar

Hyderabad: Drugs Control Administration officials seized ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg), during the raids carried out on 11th and 12th July, 2024, at a medical shop located in Karimnagar.

The product Dacarbazine Injection 500 mg sold under brand name ‘Dacazee 500 Injection’ is under price control as per Drugs (Prices Control) Order, 2013 and the price of product shall be in accordance with the ‘Ceiling Price’ fixed by National Pharmaceutical Pricing Authority (NPPA), Government of India.

The product ‘Dacazee 500 Injection’ (Dacarbazine Injection IP 500 mg) of Batch No: 323-294, Mfg. Dt: 04/2023, Exp. Dt: 03/2026, Manufactured by: Zee Laboratories Ltd., Paonta Sahib, 173025, Himachal Pradesh, bears MRP as Rs. 1,250/- for one vial (injection), on the label of the product which is a violation of Drugs (Prices Control) Order, 2013.

The Ceiling price fixed by the Central Government including Wholesale Price Index (WPI) for the product “Dacarbazine Injection 500 mg” is Rs. 518.79/- for one injection (Ceiling Price).

Hence Maximum Retail Price (MRP) i.e. including GST 12 % should not be more than Rs. 581/- for one injection (MRP=Ceiling Price+GST)

The firm overpriced the product. Firm charged an excess of Rs. 668.95/- for one injection which is a violation of the Drugs (Prices Control) Order, 2013, which is more than double the Ceiling Price fixed by the Central Government.

Further investigation shall be carried out and action shall be taken as per the law against all the offenders.

Related Posts

  • Pharma
  • July 16, 2025
  • 127 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 41 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.